Daily Archives: April 19, 2017
- Quantum Global Research Lab launches Africa Investment Index
- Morocco, Egypt, South Africa and Zambia amongst top five investment destinations
- Top five investment destinations attracted a combined net FDI of $13.6bn
LONDON, April 19, 2017 (GLOBE NEWSWIRE) — Botswana is the most attractive economy for investments flowing into the African continent, according to the latest Africa Investment Index 2016 (http://APO.af/sUtRNQ) by Quantum Global’s (www.QuantumGlobalGroup.com) independent research arm, Quantum Global Research Lab.
Multimedia content can be accessed here: http://APO.af/ZihCNl.
According to the Index, Botswana, scores highly based on a range of factors that include improved credit rating, current account ratio, import cover and ease of doing business.
Commenting on the Index, Prof Mthuli Ncube, Head of Quantum Global Research Lab stated: “Despite considerable external challenges and the fall in oil prices, many of the African nations are demonstrating an increased willingness to achieve sustainable growth by diversifying their economies and introducing favourable policies to attract inward investments. Botswana is a case in example – its strategic location, skilled workforce and a politically stable environment have attracted the attention of international investors leading to a significant influx of FDI.”
According to the report, the top five African investment destinations attracted an overall FDI of $13.6bn. Morocco was ranked second on the Index based on its increasing solid economic growth, strategic geographic positioning, increased foreign direct investment, import cover ratio, and an overall favourable business environment. Egypt was ranked third due to an increased foreign direct investment and real interest rates, and a growing urban population. The fourth country on the list, South Africa, scored well on the growth factor of GDP, ease of doing business in the country and significant population. Whilst Zambia, was the fifth country on the list due to its significant domestic investment and access money supply.
Table: Top 10 and Bottom 10 countries (view the multimedia content section: http://APO.af/1LpDdA).
Mthuli further commented: “With a population of over one billion people and rapidly growing middle class, Africa clearly offers significant opportunities to invest in the continent’s non-commodities sectors such as financial services, construction and manufacturing amongst others. However, structural reforms and greater private sector involvement are crucial to unlocking Africa’s true potential.”
Distributed by APO on behalf of Quantum Global Group.
To the editor:
Construction of the Index:
The AII is constructed from macroeconomic and financial indicators and the World Bank Group’s Ease of Doing Business Indicators (DBI). The DBI ranks countries in terms of a regulatory environment conducive to business operation. The AII focuses on 6 pillars or factors from a wider range of investment indicators, which include the share of domestic investment in GDP, the share of Africa’s total FDI net inflow, GDP growth rate forecast, population augmented GDP growth factor, real interest rate, the difference of broad money growth to the GDP growth rates, inflation differential, credit rating, import cover, the share of the country’s external debt in its GNI, current account ratio, ease of doing business and the country’s population size (Figure 1). The AII indicators are based on secondary data collected from World Bank Development Indicators, IMF World Economic Outlook, UNCTAD Data Centre and own estimates.
The AII is a combination of individual indicator’s rank into a single numerical ranking. It averages the country’s macroeconomic and financial indicators rankings on the six different factors. Each indicator, and hence factors, receives an equal weight. Their rank score is then averaged to produce the total average score which is consequently ranked from 1 to 54. The lower the value of the ranking, the better the implied business investment climate.
To produce an index score that captures medium-term changing aspects, individual country’s ranking is scaled relative to a benchmark or reference value (i.e., the past 3-year rolling average ranking). See Table 1A. In addition to the intended measurement, this approach enables us to avoid periods of structural changes (which may compromise the index) that may be present in a longer time span, whether we consider a change from a reference average value or a historical reference period.
About Quantum Global:
Quantum Global (www.QuantumGlobalGroup.com) is an international group of companies active in the areas of private equity investments, investment management as well as macroeconomic research and econometric modelling. Quantum Global’s private equity arm manages a family of funds targeting direct investments in Africa in the sectors of Agriculture, Healthcare, Hotels, Infrastructure, Mining and Timber – as well as a sector agnostic Structured Equity fund. Our team combines a solid track record and proven expertise to identify and execute unique investment opportunities with focus on Africa.
Enquiries: Linda Martin + 41 41 560 2900 media@QuantumGlobalGroup.com
Dedicated unit will focus on fintech investment and strategic partnership opportunities
NEW YORK, April 19, 2017 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq:NDAQ), one of the world’s leading providers of technology and services to the capital markets, announced today the launch of a venture investment program, Nasdaq Ventures, dedicated to discovering, investing in and partnering with unique fintech companies worldwide. The program’s main objective is to identify and collaborate on new technologies and groundbreaking services and solutions which align with Nasdaq’s clients’ needs and the company’s long-term objectives in the global capital markets.
“With the launch of our new venture investment program, we are reinforcing our focus on driving growth and innovation by evaluating, distributing, licensing and integrating disruptive technologies for the long-term benefit of our global clients,” said Adena Friedman, President and CEO, Nasdaq. “Investing in pioneering fintech firms, who are developing unique technologies, continues our history of being a platform and partner of choice for the most innovative companies in the world. In addition, through this program we plan to accelerate the pace of innovation to ensure our clients continue to benefit from the technologies that are reshaping the capital markets.”
As part of Nasdaq’s Corporate Strategy function, Nasdaq Ventures will be led by Gary Offner who will report to Jean-Jacques Louis, Head of Corporate Strategy. Offner has more than 20 years of continuous private equity, venture capital and strategic direct investment experience with an emphasis on minority growth capital investments in technology companies, and is a long-time veteran of Morgan Stanley.
The minority stake investments made by Nasdaq Ventures are expected to range from less than $1M to approximately $10M and will include seed to late-stage venture rounds. Every potential investment will receive a rigorous review with an established internal committee to ensure that each partnership is aligned with Nasdaq’s overall financial and strategic goals, as well as an existing business line or business strategy in order to guarantee that every investment furthers the company’s competitive and strategic position in the chosen businesses. Areas of initial focus will include: digital transfer/blockchain; machine learning and artificial intelligence; emerging and frontier marketplaces; and next generation data, analytics and content aggregation. The venture investing program will not have any material implications on Nasdaq’s capital allocation strategy.
Nasdaq’s investment program began unofficially in late-2015 and has since been partnered strategically with blockchain infrastructure provider Chain.com, machine intelligence company Digital Reasoning and real-time risk analytics firm Hanweck.
For potential collaboration and investment opportunities please contact Ventures@nasdaq.com.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables clients to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 85 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to approximately 3,800 listed companies with a market value of $10.1 trillion and nearly 18,000 corporate clients. To learn more, visit: business.nasdaq.com.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq’s control. These factors include, but are not limited to factors detailed in Nasdaq’s annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release revisions to any forward-looking statements.
For Media Inquiries: Nasdaq: Allan Schoenberg Allan.Schoenberg@nasdaq.com Direct: (212)231-5534 Ryan Wells firstname.lastname@example.org Direct: +44 (0) 20 3753 2231 Mobile: +44 (0) 7809 596 390
การศึกษาวิจัยใหม่ที่ตีพิมพ์ในวารสาร PLOS ONE ซึ่งเป็นการศึกษาทางวิทยาศาสตร์ขั้นสูงเกี่ยวกับ VTS-270 เพื่อรักษาโรคนีมานน์-พิค ชนิดซี 1
ROCKVILLE, Maryland, April 19, 2017 (GLOBE NEWSWIRE) — Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP) บริษัทชีวเภสัชภัณฑ์ระดับโลก วันนี้ได้ประกาศการตีพิมพ์งานวิ
NPC-1 เป็นโรคที่พบไม่บ่อย มีการลุกลาม เป็นโรคทางพันธุกรรมและมีอั
ในการศึกษาวิจัยนี้ นักวิจัยได้แสดงให้เห็นว่า VTS-270 มีระดับความสอดคล้องในปฏิกิริ
เกี่ยวกับ Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. มุ่งเน้นในการพัฒนาและทำธุรกิ
โลโก้และสโลแกนของ Sucampo, Science of Innovation เป็นเครื่องหมายการค้าจดทะเบี
ติดตามเราที่ Twitter (@Sucampo_Pharma) ติดตามเราที่ LinkedIn (Sucampo Pharmaceuticals)
ติดต่อเรา: Sucampo Pharmaceuticals, Inc. Silvia Taylor รองกรรมการผู้จัดการอาวุโส ฝ่ายนักลงทุนสัมพันธ์และองค์
กรสัมพันธ์ 1-240-223-3718 email@example.com